SOA Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

SOA Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,451	Closed	-$522	–	983
2023 Q1	$522	Hold	1,451	–	–	﹤0.01%	839
2022 Q4	$1.29K	Hold	1,451	–	–	﹤0.01%	772
2022 Q3	$2K	Hold	1,451	–	–	﹤0.01%	739
2022 Q2	$2K	Hold	1,451	–	–	﹤0.01%	727
2022 Q1	$3K	Hold	1,451	–	–	﹤0.01%	778
2021 Q4	$7K	Hold	1,451	–	–	﹤0.01%	630
2021 Q3	$11K	Hold	1,451	–	–	﹤0.01%	578
2021 Q2	$14K	Hold	1,451	–	–	﹤0.01%	521
2021 Q1	$11K	Hold	1,451	–	–	﹤0.01%	504
2020 Q4	$22K	Buy	+1,451	New	+$11.7K	0.01%	388

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

OAJ

Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.68B AUM

CFGS

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

SOA Wealth Advisors's SRNE Position: Q2 2023 in Review

SOA Wealth Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 1,451 shares — an estimated $522 sold.

SOA Wealth Advisors first reported a position in SRNE in Q4 2020 and held it in 10 quarters. The position peaked at $22K in Q4 2020. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

SOA Wealth Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
SOA Wealth Advisors sold 1,451 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $522.
SOA Wealth Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 10 quarters.
SOA Wealth Advisors's Sorrento Therapeutics, Inc. position peaked at $22K in Q4 2020.
9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on SOA Wealth Advisors's 13F filing for Q2 2023, filed 7 Jul 2023.